A

Feel confident about the safety of COPAXONE®

on
COPAXONE®
“At my doctor’s recommendation, after my first therapy was affecting my liver, I decided to begin treatment with COPAXONE®.”

—Kurt L., on COPAXONE® since 1998

Individual results may vary.

Safety is an important factor to consider when planning for long-term multiple sclerosis management. And, you can feel confident about the safety of COPAXONE®, which has been determined in the longest follow-up of relapsing-remitting multiple sclerosis (RRMS) patients ever—over 10 years and counting!1-3 COPAXONE® is not associated with serious safety warnings.4 And, you are not required to have routine blood tests and monitoring to ensure that your multiple sclerosis therapy continues to be safe for you.4 COPAXONE® has a track record you can count on—now and over the long term.1-3

A 

  • COPAXONE® is indicated for the reduction of relapses in relapsing-remitting multiple sclerosis
  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, chest pain, weakness, infection, pain, nausea, joint pain, anxiety, and muscle stiffness. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects
  • Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems
  • A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes
  • After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again

077005412/071103
A
References:
  1. Ford CC, Johnson KP, Lisak RP, et al. Mult Scler. 2006;12:309-320.
  2. Johnson KP, Brooks BR, Cohen JA, et al. Neurology. 1995;45:1268-1276.
  3. Data on file. Teva Neuroscience, Inc.
  4. COPAXONE® prescribing information, 5/07. Teva Neuroscience, Inc.